Healthcare (Substance Abuse)

failed · New York · Assembly Apr 21, 2026

A 9126: Relates to prohibiting supervised injection sites

Relates to prohibiting supervised injection sites; provides that it shall be unlawful for any person to own, operate, work in or volunteer at a supervised injection site; defines terms and establishes penalties.

Topics ✗ Criminal JusticeOpposes Criminal JusticeProhibits supervised injection sites, a harm reduction approach in criminal justice reform, expanding criminalization of drug use and restricting reform efforts.90% confidence ✗ HealthcareOpposes HealthcareProhibits supervised injection sites, a public health service for harm reduction, restricting access to healthcare services.95% confidence

Sub-Topics Substance Abuse

Track

in committee · New York · Senate Jan 7, 2026

S 1973: Relates to prohibiting supervised injection sites

Relates to prohibiting supervised injection sites; provides that it shall be unlawful for any person to own, operate, work in or volunteer at a supervised injection site; defines terms and establishes penalties.

Topics ✗ Criminal JusticeOpposes Criminal JusticeBill prohibits supervised injection sites, opposing harm reduction initiatives in criminal justice reform that reduce drug-related offenses through medical supervision.95% confidence ✗ HealthcareOpposes HealthcareBill prohibits supervised injection sites, which are public health services for harm reduction, restricting access to a healthcare-related program.92% confidence

Sub-Topics Drug Policy Substance Abuse

Track

in committee · New York · Senate Jan 7, 2026

S 732: Relates to prescribing opioids to a minor

Relates to prescribing opioids to a minor; prohibits practitioners from prescribing to a minor more than a seven day supply of any controlled substance containing an opioid; requires practitioners to obtain written parental consent before issuing a first prescription of a controlled substance containing an opioid to a minor; establishes exceptions.

Topics ✗ HealthcareOpposes HealthcareBill restricts opioid prescriptions to minors by limiting supply and requiring consent, limiting patient access to controlled substances under healthcare guidelines.90% confidence

Sub-Topics Substance Abuse

Track

in committee · New York · Senate Jan 7, 2026

S 3351: Adds tianeptine sodium to the list of Schedule II of controlled substances

This bill adds tianeptine sodium to New York's Schedule II controlled substances list, which includes drugs with high abuse potential but recognized medical uses (like certain opioids). It directly affects healthcare providers who prescribe it, pharmacies that dispense it, and patients who use it, requiring stricter controls such as special prescriptions and recordkeeping. The law amends the public health law to include tianeptine sodium in Schedule II, aligning its regulation with other high-risk medications. The change takes effect 90 days after enactment.

Topics ✗ HealthcareOpposes HealthcareRestricts healthcare access by imposing Schedule II controls on tianeptine sodium, requiring special prescriptions and recordkeeping for providers and patients.90% confidence

Sub-Topics Public Health Substance Abuse

Track

in committee · New York · Senate Apr 21, 2026

S 8033: Prohibits incarcerated individuals suffering from a substance use disorder from being prescribed medications for a different disorder

Prohibits incarcerated individuals who are determined to suffer from a substance use disorder for which there is no FDA approved addiction medications from being administered medication approved for a different disorder.

Topics ✗ Criminal JusticeOpposes Criminal JusticeRestricts medication access for substance use disorders in prison, limiting rehabilitation efforts which weakens correctional treatment programs.85% confidence ✗ HealthcareOpposes HealthcareBill explicitly restricts medication access for incarcerated individuals with substance use disorder, limiting treatment options and thus restricting healthcare access for this population.90% confidence

Sub-Topics Corrections Drug Policy Substance Abuse

Track